What happened in optometry this week: February 5-February 9

Blog
Article

Catch up on what happened in optometry during the week of February 5-February 9.

Catch up with what Optometry Times shared this week:

FDA accepts IND for OK-101 for neuropathic corneal pain

By Emily Kaiser Maharjan, Assistant Managing Editor

OKYO Pharma announced the acceptance of OK-101 as an investigational new drug following clinical studies investigating the candidate in patients with neuropathic corneal pain, the first to do so.

Read here...

UC optometrists strike over “bad-faith” bargaining practices, protest low salaries

By Jordana Joy, Associate Editor

Members of the University Professional and Technical Employees CWA Local 9119 drew picket lines on February 6 and 7 to protest unfair labor and bargaining practices upheld by University of California.

Read here...

Gaps in vision screening for school-aged children uncovered in study

By Lynda Charters

A new study found that only a little over half of school-aged children participants underwent vision screening within the past two years, highlighting gaps in eye care access.

Read here...

Diagnosing and treating Demodex blepharitis

By Amy Nau, OD, Dipl CCLRT; Lynda Charters

Everything, no matter how minute, has a purpose and so that must also be the case for the pesky Demodex mite, the infective parasites that lie between or on the eyelashes in highly sebaceous areas. Some researchers think these parasites may help control bacterial populations through their acidic secretions. However, their waste can cause inflammation and hypersensitivity reactions in affected individuals.

Read here...

ALSTAR study identifies potential functional biomarker for early, intermediate AMD

By Lynda Charters

The study further defined the relationship between delayed rod-mediated dark adaptation and the status of outer retinal bands on optical coherence tomography.

Read here...

Recent Videos
Tracy Doll, OD, FAAO, details portions of the Tear Film and Ocular Surface Society Lifestyle Report, which discussed certain risk factors that we may have for development of ocular surface dryness or dry eye.
Christi Closson, OD, FAAO, provides insight on what other ODs learned about Johnson & Johnson's contact lens technology.
Erich Hinel, OD, MS, FAAO, provided an overview of his presentation, which focused on the approach clinicians should take when evaluating a patient with suspected scleritis.
Dana Shannon, OD, FAAO, details The Contact Lens Instiute's latest report, The Dropout Dilemma.
Dr. Lisa Hornick details an interactive AAOpt talk utilizing the game of Jeopardy and dry eye
Billy R. Hammond details the study, which explored how HEV-light filtering, specifically in the 380-440 nanometer range, impacts visual comfort for patients with presbyopia.
Dr Andrew Pucker at the American Academy of Optometry meeting in 2024
Steve Ferrucci, OD, FAAO, discussed the detection and treatment of geographic atrophy during his AAOpt 2024 lecture, "Imaging Techniques and Emerging Therapies for Geographic Atrophy."
Dr. Jessilin Quint gives an overview on next steps after treating dry eye
Ahmad Fahmy at AAOpt on neurotrophic pain in OSD
© 2024 MJH Life Sciences

All rights reserved.